Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma models is a research paper published in Journal of Clinical Investigation (2025). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R21CA282543,2K12CA226330-06,1R01NS110703-01A1,1U19CA264338-01,P30CA240139
Elsa Pardee Foundation
Grant: PARDEE-2024-01
UM American Cancer Society Intramural Funding
Grant: ACSP-2023-01
Florida Center for Brain Tumor Research
Grant: FCBTR-2022-01
Neurosurgery Research and Education Foundation
Grant: NREF-2022-01
Dwoskin Family Fund
Grant: N/A
NINDS NIH HHS
Grant: R01 NS110703
NCI NIH HHS
Grant: R21 CA282543
NCI NIH HHS
Grant: U19 CA264338
NCI NIH HHS
Grant: K12 CA226330
NCI NIH HHS
Grant: P30 CA240139
National Institutes of Health
Grant: 1R01NS110703-01A1
MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy
National Institutes of Health
Grant: 3P30CA240139-02S3
The Sylvester Cancer Center Support Grant
National Institutes of Health
Grant: 2K12CA226330-06
UM Calabresi Clinical Oncology Research Career Development Award
National Institutes of Health
Grant: 1U19CA264338-01
Advancing treatment and understanding of immunotherapy in glioblastoma
National Institutes of Health
Grant: 5R21CA282543-02
A Phase 2 biomarker driven, Study of DB107, a Retroviral Replicating Vector, Combined With 5-FC in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma
Fields of Study
MeSH Terms
Keywords